News and Comments

INCYTE: SHOWS ITS PATH TOWARDS GROWTH

  Wednesday, February 12, 2014

 More...

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Prosensa (RNA) Prolor Biotech (PBTH) Tysabri ARCA (ABIO) Pluristem (PSTI) Human Longevity (HLI) Zerenex Gilead (GILD) Elan (ELN) Exelixis (EXEL) GUARDIAN HEALTH Benlysta (belimumab) OSI (OSIP) KERYX (KERX) Anadys (ANDS) Sequenom (SQNM) CompuGen (CGEN) PTC Therapeutics (PTCT) Amgen (AMGN) Alder Biopharmaceuticals (ALDR) Inovio (INO) Abbott Laboratories (ABT) VANDA (VNDA) NEKTAR (NKTR)) Xoma (XOMA) IDERA (IDRA) Intrexon (XON) C4 Therapeutics Idenix (IDIX) Ionis (IONS) TOKAI (TKAOI) Ziofpharm (ZIOP) galapagos (GLPG) Genentech Aimmune Therapeutics (AIMT) Alnylam (ALNY) Rapamune Agenus (AGEN) SUNESIS PHARMACEUTICALS (SNSS) Dynavax (DVAX) KITE (KITE) Telaprevir ACADIA (ACAD) MODERNA Sanofi-Aventis (SAN) Bristol-Myers Squibb (BMY) Roche (RHHBY) SYNTA (SNTA) Illumina (ILMN) AERIE PHARMACEUTICALS Theravance (THRX) Ridaforolimus Cytokinetics (CYTK) Intercept (ICPT) Anacor (ANAC) REGULUS (RGLS) AGOS (ARGS) Herceptin Regeneron (REGN) ABBVIE (ABBV) BIOMARIN (BMRN) Ariad (ARIA) Theravance Bio Pharma (TBPH) ZALTRAP™ ADVENTRIX (ANX) Sarepta (SRPT) Vertex (VRTX) Seattle Genetics (SGEN) NOVOCURE (NVCR) Sanofi (SNY) Endometrial Cancer Galena (GALE) Onyx (ONXX) Valeant Pharmaceuticals International (VRX) ImmunoGen (IMGN) Sanofi (SNA) GlaxoSmithKline (GSK) Array Pharmaceuticals (ARRY) Velcade (bortezomib) Global Cell Therapeutics (GBT) NANTKWEST (NK) Intermune (ITMN) Agenus (AGEN Micromet (MITI) Multiple Myeloma JUNO (JUNO) Roche (ROCHE) Human Genome Sciences (HGSI) Merck (MRK) Editas (EDIT) Spike Therapeutics (ONCE) Revlimid (lenolidamide) Vitae Pharmaceuticals (VTAE) Sangamo (SGMO) Biogen Idec (BIIB) Incyte (INCY) Trastuzumab-DM1 HALOZYME (HALO) Biocryst (BCRX) Mirati Therapeutics (MRTX) Auspex (ASPX) INNOVIVA (INVA) Dendreon (DNDN) RenenxBio (RGNX) SERES THERAPEUTICS (MCRB) ISIS (ISIS) Jazz Pharmaceuticals (JAZZ) AstraZeneca (AZN) ARGOS (ARGS)